XII Jornada Mineira de Radiologia
1º Dia - 6/19/26
2º Dia - 6/20/26

PET-FDG no Linfoma: avaliação de resposta precoce e tardia Voltar

Stephanie Saliba

Curso: Medicina Nuclear - Sessão 3 - Linfomas - Elba Etchebehere e Stephanie Saliba

Artigo Autor(es) Referência
ESR Essentials: imaging of lymphoma-practice recommendations by the European Society of Oncologic Imaging. Leithner Doris, Neri Emanuele, D'Anastasi Melvin, Schlemmer Heinz-Peter, Winkelmann Michael, Kunz Wolfgang G, Cyran Clemens C, Cioni Dania, Sala Evis, Mayerhoefer Marius E European radiology. 2025 Jul; 35(Jul):4387-4394. doi: 10.1007/s00330-024-11213-5. pii: .
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Barrington Sally F, Kluge Regine European journal of nuclear medicine and molecular imaging. 2017 Aug; 44(Aug):97-110. doi: 10.1007/s00259-017-3690-8. pii: .
Interim FDG-PET/CT for Response Assessment of Lymphoma. Zeman Merissa N, Akin Esma A, Merryman Reid W, Jacene Heather A Seminars in nuclear medicine. 2023 May; 53(May):371-388. doi: 10.1053/j.semnuclmed.2022.10.004. pii: S0001-2998(22)00092-7.
Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now? Mikhaeel N George Leukemia & lymphoma. 2009 Dec; 50(Dec):1931-6. doi: 10.3109/10428190903275610. pii: .
Is [(18)F]fluorodeoxyglucose positron emission tomography the ultimate tool for response and prognosis assessment? Brepoels Lieselot, Stroobants Sigrid Hematology/oncology clinics of North America. 2007 Oct; 21(Oct):855-69.
Overview of early response assessment in lymphoma with FDG-PET. MacManus Michael P, Seymour John F, Hicks Rodney J Cancer imaging : the official publication of the International Cancer Imaging Society. 2007 ; 7():10-8.
PET and PET/CT for response evaluation in lymphoma: current practice and developments. Brepoels Lieselot, Stroobants Sigrid, Verhoef Gregor Leukemia & lymphoma. 2007 Feb; 48(Feb):270-82.
Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update. Juweid Malik E, Mueller Marguerite, Alhouri Abdullah, A-Risheq M Ziad, Mottaghy Felix M Cancer. 2021 Oct; 127(Oct):3727-3741. doi: 10.1002/cncr.33772. pii: .
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Cheson Bruce D, Fisher Richard I, Barrington Sally F, Cavalli Franco, Schwartz Lawrence H, Zucca Emanuele, Lister T Andrew, , , , , , , , , , , , , , , Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Sep; 32(Sep):3059-68.
[18F-fluorodeoxyglucose positron emission tomography in the evaluation of therapy response assessment in lymphomas. Systematic literature review and meta-analysis]. Ramos-Font C, Rebollo Aguirre A C, Villegas Portero R, Romero Tabares A, Gallego Peinado M, Llamas Elvira J M Revista espanola de medicina nuclear. 2009 ; 28():48-55.
Nenhuma revista foi definida para este congresso.